Clinical Trial Update: Adalimumab for the Management of Post-operative Crohn's Disease (CD) [Phase 3]

View source ↗

Summary

A Phase 3 trial is assessing adalimumab for managing post-operative Crohn's disease, with the trial status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Crohn Disease | Phase 3 | Status: UNKNOWN